Gli as a Novel Therapeutic Target in Malignant Pleural Mesothelioma

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Li, Hui ^a   Lui, Natalie ^a   Cheng, Tiffany ^a   Tseng, Hsin Hui K ^a   Yue, Dongsheng ^a,c   Giroux Leprieur, Etienne ^a   Do, Hanh T ^a   Sheng, Qing ^a,b   Jin, Joy Q ^a   Luh, Thomas W ^a   Jablons, David M ^a   He, Biao ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ZHEJIANG SCI TECH UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PEMETREXED; PROTEIN PATCHED 1; PROTEIN PATCHED 2; SMALL INTERFERING RNA; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI1 INHIBITOR; TRANSCRIPTION FACTOR GLI2; UNCLASSIFIED DRUG; VISMODEGIB;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DOWN REGULATION; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PLEURA MESOTHELIOMA; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR VOLUME; TUMOR XENOGRAFT;

AGED; ANILIDES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; DRUG SYNERGISM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAMATES; GUANINE; HEDGEHOG PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MESOTHELIOMA; MICE; MICE, NUDE; MOLECULAR TARGETED THERAPY; NUCLEAR PROTEINS; PLEURAL NEOPLASMS; PYRIDINES; RECEPTORS, G-PROTEIN-COUPLED; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84874594295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057346     Document Type: Article

References (35)

1. Crispi S, Cardillo I, Spugnini EP, Citro G, Menegozzo S, et al. (2010) Biological Agents Involved in Malignant Mesothelioma: Relevance as Biomarkers or Therapeutic Targets. Current Cancer Drug Targets 10: 19-26.
2. Tsao AS, Wistuba I, Roth JA, Kindler HL, (2009) Malignant Pleural Mesothelioma. Journal of Clinical Oncology 27: 2081-2090.
3. Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, et al. (2012) Malignant Mesothelioma: Facts, Myths, and Hypotheses. Journal of Cellular Physiology 227: 44-58.
4. Greillier L, Marco S, Barlesi F, (2011) Targeted therapies in malignant pleural mesothelioma: a review of clinical studies. Anti-Cancer Drugs 22: 199-205.
5. Sekido Y, (2009) Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells. Cancer Science 101: 1-6.
6. Zucali PA, Ceresoli GL, De Vincenzo F, Simonelli M, Lorenzi E, et al. (2011) Advances in the biology of malignant pleural mesothelioma. Cancer Treatment Reviews 37: 543-558.
7. Carbone M, Yang HN, (2012) Molecular Pathways: Targeting Mechanisms of Asbestos and Erionite Carcinogenesis in Mesothelioma. Clinical Cancer Research 18: 598-604.
8. Mimeault M, Batra SK, (2010) Frequent Deregulations in the Hedgehog Signaling Network and Cross-Talks with the Epidermal Growth Factor Receptor Pathway Involved in Cancer Progression and Targeted Therapies. Pharmacological Reviews 62: 497-524.
9. Lauth M, Toftgard R, (2007) Non-canonical activation of GLI transcription factors- Implications for targeted anti-cancer therapy. Cell Cycle 6: 2458-2463.
10. Lauth M, Toftgard R, (2007) The Hedgehog pathway as a drug target in cancer therapy. Current Opinion in Investigational Drugs 8: 457-461.
11. Stanton BZ, Peng LF, (2009) Small-molecule modulators of the Sonic Hedgehog signaling pathway. Molecular Biosystems 6: 44-54.
12. Ng JMY, Curran T, (2011) The Hedgehog's tale: developing strategies for targeting cancer. Nature Reviews Cancer 11: 493-501.
13. LoRusso PM, Rudin CM, Reddy JC, Tibes R, Weiss GJ, et al. (2011) Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors. Clinical Cancer Research 17: 2502-2511.
14. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, et al. (2012) Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma. New England Journal of Medicine 366: 2171-2179.
15. Dlugosz A, Agrawal S, Kirkpatrick P, (2012) Vismodegib. Nature Reviews Drug Discovery 11: 437-438.
16. Tostar U, Malm CJ, Meis-Kindblom JM, Kindblom LG, Toftgard R, et al. (2006) Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development. Journal of Pathology 208: 17-25.
17. Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, et al. (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236: 70-73.
18. Chi SM, Huang SH, Li CX, Zhang XL, He NG, et al. (2006) Activation of the hedgehog pathway in a subset of lung cancers. Cancer Letters 244: 53-60.
19. Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, et al. (2006) Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. Journal of Clinical Oncology 24: 1924-1931.
20. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, et al. (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425: 851-856.
21. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, et al. (2002) Mutations in SUFU predispose to medulloblastoma. Nature Genetics 31: 306-310.
22. Hui CC, Angers S (2011) Gli Proteins in Development and Disease. Annual Review of Cell and Developmental Biology, Vol 27. Palo Alto: Annual Reviews. 513-537.
23. Bigelow RLH, Jen EY, Delehedde M, Chari NS, McDonnell TJ, (2005) Sonic hedgehog induces epidermal growth factor dependent matrix infiltration in HaCaT keratinocytes. Journal of Investigative Dermatology 124: 457-465.
24. Dennler S, Andre J, Verrecchia F, Mauviel A, (2009) Cloning Of The Human Gli2 Promoter: Transcriptional Activation By Tgf-Beta In Keratinocytes Via Smad3/beta-Catenin Cooperation. Journal of Investigative Dermatology 129: S85-S85.
25. Javelaud D, Mauviel A, (2005) Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 24: 5742-5750.
26. Ji ZY, Mei FC, Xie JW, Cheng XD, (2007) Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. Journal of Biological Chemistry 282: 14048-14055.
27. Kasper M, Schnidar H, Neill GW, Hanneder M, Klingler S, et al. (2006) Selective modulation of hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Molecular and Cellular Biology 26: 6283-6298.
28. Riobo NA, Haines GM, Emerson CP, (2006) Protein kinase C-delta and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling. Cancer Research 66: 839-845.
29. Riobo NA, Lu K, Ai XB, Haines GM, Emerson CP, (2006) Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proceedings of the National Academy of Sciences of the United States of America 103: 4505-4510.
30. Seto M, Ohta M, Asaoka Y, Ikenoue T, Tada M, et al. (2009) Regulation of the Hedgehog Signaling by the Mitogen-Activated Protein Kinase Cascade in Gastric Cancer. Molecular Carcinogenesis 48: 703-712.
31. Siegel PM, Massague J, (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nature Reviews Cancer 3: 807-820.
32. Stecca B, Mas C, Clement V, Zbinden M, Correa R, et al. (2007) Melanomas require HEDGEHOG-GLI signaling reaulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proceedings of the National Academy of Sciences of the United States of America 104: 5895-5900.
33. He B NF, Liang Y, Xu Z, Jablons DM (2010) Targeting GLI proteins in human cancer by small molecules. United States patent US 6,885,550.
34. Dodge ME, Lum L, (2011) Drugging the Cancer Stem Cell Compartment: Lessons Learned from the Hedgehog and Wnt Signal Transduction Pathways. Annual Review of Pharmacology and Toxicology, Vol 51 2011: 289-310.
35. Shi Y, Moura U, Opitz I, Soltermann A, Rehrauer H, et al. (2012) Role of Hedgehog Signaling in Malignant Pleural Mesothelioma. Clinical Cancer Research 18: 4646-4656.